US equities
|
NVDA
$136.84
▼-6.26%
ANT
$87.25
▼-10.21%
MU
$620.67
▼-10.11%
AMD
$446.95
▼-8.63%
SPCX
$129.99
▼-6.10%
AAPL
$348.74
▼-0.14%
AMZN
$255.07
▼-0.89%
MSFT
$494.70
▼-0.72%
NVDA
$136.84
▼-6.26%
ANT
$87.25
▼-10.21%
MU
$620.67
▼-10.11%
AMD
$446.95
▼-8.63%
SPCX
$129.99
▼-6.10%
AAPL
$348.74
▼-0.14%
AMZN
$255.07
▼-0.89%
MSFT
$494.70
▼-0.72%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NYSEAMERICAN:SENS,NASDSAQ:DXCM
Recent news which mentions NYSEAMERICAN:SENS,NASDSAQ:DXCM
FDA Approval for Senseonics’ Glucose Monitor Could Double the Stock Price
October 18, 2021
Tickers
DXCM
SENS
Tags
Market News
NYSEAMERICAN:SENS,NASDSAQ:DXCM
DXCM
From
InvestorPlace